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Abstract
Background: Fournier’s gangrene is a devastating condition that affects mostly patients whose immunity has been reduced. 
There is increasing evidence for increasing incidence of  the disease in those with HIV disease. 
Objective: To evaluate the presentation, bacteriology and outcome of  Fournier’s gangrene in our area in recent times in 
view of  the high prevalence  in Nairobi and its environs. 
Results: One hundred and forty six patients were treated for Fournier’s gangrene during the study period; all were male. 
They had a mean age of  38.6 years (range 2 months – 86 years). HIV infection was the most common associated underlying 
illness (16.4 %), followed by diabetes mellitus and alcoholism (11%). 
Conclusions: HIV infection is emerging as leading predisposing factor and has overtaken diabetes in predisposing  for 
Fournier’s gangrene in Kenyatta National Hospital. 
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Introduction 
Fournier’s gangrene is an uncommon disease that is 
easy to diagnose and whose principles of  treatment are 
clear but for which treatment outcome remains poor 
with high morbidity and mortality1. In a review of  pub-
lications in English literature from 1966 to 1999 Eke et 
al and noted that there was consensus on early recogni-
tion, urgent resuscitation, use of  multiple anti microbial 
agents, and surgical debridement as the principles of  
its management. Controversy however, remains on the 
role of  conservative treatment in the form of  wound 
dressing, use of  honey or the benefits of  hyperbaric 
oxygen2,3,4. Laor et al developed the Fournier’s gangrene 
severity index score by studying the physiological and 
laboratory  parameters in 30 patients and modifying the 
acute physiology and chronic health score APACHE, 
to generate a simple and objective measure for prog-
nostication; the Fournier gangrene severity index score. 
FGSIS5. This has been validated by other studies6,7,8. 
The strength of  this score lies in its indication of  physi-
ological state and metabolic derangements at admission 
and during treatment; which ultimately contribute to 
outcome.
Ayumba  et al  studied  Fournier’s gangrene at Kenyatta 
National hospital Nairobi, highlighting some aspects 
of  epidemiology and outlining the management of  the 
condition in this setting9,10. This was about a decade ago 
and it is likely that the situation has changed over the 
years. The purpose of  this study was to evaluate the 
presentation, investigations, associated illnesses, man-
agement and outcome of  Fournier’s gangrene over the 
past decade in the same setting particularly in view of  
increased HIV infections. 
Materials and methods
This was a retrospective review of  all patients treated 
for Fournier’s gangrene at Kenyatta  National  Hospi-
tal  between  1st   January  1998  and  31st   Decem-
ber  2007. Ethical  approval  was  sought  and granted 
by  the  Kenyatta  National  Hospital  Ethical Review 
Committee.  The files were identified after listing all 
the names of  patients listed as having been treated for 
Fournier’s gangrene at the Kenyatta National hospital 
during the study period.  A questionnaire was used to 
extract data from all patients listed   in the medical re-
cords department as having been treated for Fournier’s 
gangrene during the study period. This questionnaire 
was different from the one used by the previous group 
but no internal validity for the questionnaire had been 
done. Only patients whose files could be traced were 
used in the study. One hundred and fourty six patients 
were listed as having been treated for Fournier’s gan-
grene during the period under review. The questionnaire 
sought information on patients demographic data, the 
presenting symptoms, primary source and anatomical 
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The commonest presenting symptom was a perineal 
swelling in 95% (140 patients), followed by pain and fe-
ver in 79.5 % (116 patients) and   ulceration in the peri-
neum in 52.2 % (77 patients). Other symptoms were 
found in 11.6% (17) of  the patients. (Table II)
The perineum was listed as the only site involved in 
56.2 % (82 patients) the scrotum and penis in 26.7 % 
(39 patients) and the groin in 17.1 % (25 patients). A 
minority of  patients had more extensive disease with 
involvement of  the lower abdominal wall in 6.8% (10 
patients) and chest wall involvement in 0.7% (1 patient) 
(Table II)
Perineal skin was the commonest origin of  the infec-
tion and was found in 46.6% (68 patients) followed by 
the genitourinary tract in 28.8% (42 patients) and the 
ano-rectal region in 13.7% (20 patients). The source of  
infection could not be determined in 11% (16(patients). 
(Table II)
The associated underlying illnesses included Human 
Immunodeficiency Virus infection  in  16.4%  (24  pa-
tients),  diabetes  mellitus  in  11%  (16  patients),  and 
alcoholism in 11% (16 patients), and malignancy in 
2.7% (4 patients), and steroid use in 0.7% (1 patient).
Predisposing conditions included perineal abscesses 
28.1% (41 patients), complicated inguinal hernia 28.1% 
(41 patients), perineal abscess with tuberculosis 1.4% 
(2 patients), and   inguinal hernia with HIV 1.4% (2 pa-
tients) and skin sepsis sepsis 0.7% (1patient).  In 40.4% 
(59 patients) no predisposing condition was found (Ta-
ble II).
Empirical broad-spectrum antibiotic cover was initiated 
in all the patients. The drugs used included metronida-
zole in 119(81.5%,) crystalline penicillin in 65(44.8%) 
gentamycin  in  45(30.8%),  ceftriaxone  in  30(21%), 
amoxicillin/clavulanic  acid  in 23(16%) and ampicillin/
cloxacillin in 29(20%) patients Others antibiotics were 
less frequently used. The antibiotics were then revised 
based on culture and sensitivity test results. 
The majority, 40.4% (59 patients) stayed in the hospital 
for two weeks, 23.3% (34 patients) stayed for one week 
and 36.3% (53 patients) for 3 or more weeks. Thirty 
five patients 24% (35 patients) stayed for more than 4 
weeks. (TableIII)
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Table II Anatomic distribution primary source predisposing factors, and hospital stay
Anatomic distroibution                n               % 
perineum  82  56.2 
scrotal  39  26.7 
penile  39  26.7 
groin  25  17.1 
low abdominal wall 10  6.8 
chest  1  0.7 
other  12  8.2 
primary source    
skin  68  46.6 
genitourinary 42  28.8 
colorectal   20  13.7 
not indicated 16  11 
predisposing condition    
Perineal abscess 68  28.1 
perineal TB  43  1.4 
inguinal hernia with or without HIV 20  29.5 
skin sepsis  1  0.7 
none found  59  40.4 
hospital stay    
<1 week  34  23.3 
1-2 weeks  59  40.4 
3-4 weeks  18  12.3 
>4 weeks  35  24 
     
 
distribution of  the disease were recorded. It also had 
questions on the investigations done, the treatment 
given, the procedures done and antibiotics used.  Out-
come data on morbidity and mortality was also record-
ed. The extracted data was checked for inconsistencies 
and validated after which the data was then entered into 
a Microsoft Excel™ spreadsheet and analyzed using 
the Statistical Package for Social Sciences (SPSS ver. 
15, SPSS Inc.). Data was cleaned and exploratory data 
analysis undertaken to identify the nature of  the distri-
butions for informing the right statistical procedures. 
Descriptive statistics was conducted for the following 
socio-demographic variables: the presenting symp-
toms, anatomic distribution of  the disease, the primary 
sources, predisposing condition, and duration of  hos-
pital stay. Spearman correlation analysis was conducted 
between hospital stay and the continuous variables. An 
independent sample t-test was for normally distribution 
variable and the complications. Since hospital stay was 
skewed to the right (not normally distributed), Mann-
Whitney U- statistics for Median (Non-parametric) was 
used. The hospital stay was later re- grouped and in-
dependence test was done using chi-square techniques. 
P-value of  less than  0.05  was  considered  statistically 
significant.  For  categorical  variables  the hospital stay 
was re-grouped and independence test was done. P-
value of  less than
0.05 was considered statistically significant. 
Results
A total of  146 patients were treated for Fournier’s 
gangrene in the study period. The mean age was 38.6 
years, median age of  35.0 years, with a range of  86 years 
(0-86) (Figure I). All the patients were male. All files of  
patients recorded as Fournier’s gangrene were traced. It 
is probable that some patients might have been missed 
because of  their not having been labeled as fournier’s 
gangrene but this was not quantifiable.
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The distribution according to area of  residence showed 
that 61% (90 patients) were from the city of  Nairobi 
and the rest from rural areas. 74% (109 patients) had re-
ceived only primary school education or less with only 
1.4% (2 patients) having completed university educa-
tion. 53%  (78 patients) were unemployed. (Table I)
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             Table I: Socio-demographic factors
  frequency  percent 
     
Residence     
urban  90  61.6 
rural  55      37.7 
forighner  1      0.7 
level of education    
none   50      34.2 
primary  59      40.4 
secondary school 26      17.8 
college  9      62 
university  2      1.4 
occupation     
business  27      34.2 
civil servant  6      4.1 
employed  13      8.9 
unemployed  78      53.4 
other  22      15.1 
presenting symptoms    
swelling  140      95 
pain   116      79.5 
fever  116      79.5 
ulceration  77      52.7 
other  17      11.6 
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The age distribution of  the patients in this study as in 
contemporary literature2,9,15 shows the majority of  pa-
tients were in the 30-60 year age bracket. The mean age 
of  diagnosis has been rising since Fournier described 
the condition, with recent reports indicating mean age 
of  diagnosis rising from 40s to 60s. The most notable 
characteristic is association of  Fournier’s gangrene with 
an underlying systemic disease more so immuno-com-
promising diseases such as malignancy, steroid use, and 
recently HIV. The prevalence of  these diseases increas-
es the incidence of  Fournier’s gangrene.2,9,15 
Over  the  years  this  eponym  Fournier’s  gangrene  has 
been  used  for  fulminant gangrene in other regions 
of  the body such as the perineum, anterior abdominal 
and chest wall sometimes in the axilla11,12. Wilson de-
scribed the underlying pathology as necrotizing fasciitis 
of  deep fascia with subsequent loss of  all the overlying 
skin and subcutaneous tissues.13.
Fournier’s gangrene has been reported from all parts of  
the world. It is relatively a rare disease with an estimated 
incidence of  1:7500.14 It remains  predominantly a male 
disease with  a male to female ratio of  10:12,14 and it  has 
been described in all age groups including children2,9. 
The male predominance of  the condition in this study 
and only 146 patients having been treated over in 10 
years agrees with these earlier findings.
A dedicated search for the primary source will trace the 
portal of  entry. In many cases, the source of  sepsis is 
traced to local skin lesions, urogenital or colo-rectal re-
gion.16 A fraction of  the patients still yield no identifi-
able source and were deemed idiopathic.
Systemic  illnesses  are  common  in  Fournier’s  gan-
grene; the  most  reported  being diabetes mellitus. Oth-
ers include advanced malignancies especially in colorec-
tal region,  use  of   cytotoxics,  or  steroids,  and  lately 
the  HIV-AIDS  among  others. Ayumba et al showed 
60% association with diabetes mellitus, 4.0% with HIV 
AIDS. 
There is a fear that HIV pandemic might lead to a rise 
of  Fournier’s gangrene in Africa.
Whereas diabetes mellitus is found to be the main co 
morbidity in western literature2,9,15  occurring in as many 
as 60% of  patients, we found that HIV infection was 
the main associated illness in our set up with diabetes 
and alcoholism being the second most common. This 
could be due to the higher sero-prevalence of  HIV in 
our source population. Whereas in the Ayumba series10 
only four percent of  the patients had HIV in our series 
10 years later 16 % had HIV However, Efem18 reported 
a series of  20 Nigerian patients with none of  them hav-
ing HIV infection. Thus the main consideration is the 
hosts lowered immunity rather than the cause of  the 
lowered immunity.
Alcoholism was found to be a major contributing factor 
(11%). Alcoholism lowers host immunity by inducing a 
state of  malnutrition and also encourages perineal sep-
sis due to the associated poor hygiene. There is also a 
delay in seeking intervention due to masking of  symp-
toms such as pain because of  altered mental state
The mortality of  20.5% and long hospital stay concur 
with earlier literature19. In the study by Ayumba9 two of  
the 46 patients died 4% whereas in our study 30 of  the 
146 patients died (20.5%) indicating an increased sever-
ity of  the disease in the study period. It affects the un-
educated and unemployed more with level of  education 
affecting outcome. This could also be a reflection of  
lower socio-economic status being a marker for poorer 
outcomes.
The  presence  of   complications  increases  the  length 
of   hospital  stay  as  well  as mortality.
The disease affects primarily the perineum and our 
study shows that in 50 % of  the time only the perineum 
was involved.
Thirty of  the 146 patients died (20.5%). The most com-
mon cause of  death was overwhelming sepsis (90%). 
Other causes of  death included coagulopathy (3.3%), 
acute renal failure (3.3%) and multiple organ dysfunc-
tion (3.3%). Overwhelming sepsis thus remains a main 
contributor to mortality in these patients.
Conclusion
HIV may be emerging as an important predisposing 
factor for Fournier’s gangrene in our setting and may 
have overtaken diabetes. The incidence and severity of  
Fournier’s gangrene  appears  to  be  increasing  in  this 
era  of   HIV  disease,  causing  a  lot  of  morbidity and 
mortality. Further research is needed on this relation-
ship between HIV infection and Fournier’s gangrene. 
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Table III: Relationship between hospital stay with other factors
 Complications P-value 
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Duration (weeks) 
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